DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2023 Earnings Call Transcript

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2023 Earnings Call Transcript May 16, 2023

DiaMedica Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.16.

Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2023 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica’s website at www.diamedica.com in the Investor Relations section. Before the...